DE69429868D1 - Verfahren zur herstellung eines inter-alpha-trypsin inhibitor konzentrats mit therapeutischer anwendung und so erhaltenes konzentrat - Google Patents
Verfahren zur herstellung eines inter-alpha-trypsin inhibitor konzentrats mit therapeutischer anwendung und so erhaltenes konzentratInfo
- Publication number
- DE69429868D1 DE69429868D1 DE69429868T DE69429868T DE69429868D1 DE 69429868 D1 DE69429868 D1 DE 69429868D1 DE 69429868 T DE69429868 T DE 69429868T DE 69429868 T DE69429868 T DE 69429868T DE 69429868 D1 DE69429868 D1 DE 69429868D1
- Authority
- DE
- Germany
- Prior art keywords
- concentrate
- pct
- alpha
- inter
- trypsin inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9312346A FR2711371B1 (fr) | 1993-10-18 | 1993-10-18 | Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu. |
PCT/FR1994/001197 WO1995011260A1 (fr) | 1993-10-18 | 1994-10-17 | Procede de preparation d'un concentre d'inter-alpha-trypsine inhibiteur a usage therapeutique et concentre obtenu |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69429868D1 true DE69429868D1 (de) | 2002-03-21 |
DE69429868T2 DE69429868T2 (de) | 2002-09-19 |
Family
ID=9451908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69429868T Expired - Lifetime DE69429868T2 (de) | 1993-10-18 | 1994-10-17 | Verfahren zur herstellung eines inter-alpha-trypsin inhibitor konzentrats mit therapeutischer anwendung und so erhaltenes konzentrat |
Country Status (12)
Country | Link |
---|---|
US (1) | US5777081A (de) |
EP (1) | EP0724600B1 (de) |
JP (1) | JP3650937B2 (de) |
AT (1) | ATE213252T1 (de) |
AU (1) | AU7996294A (de) |
CA (1) | CA2174231C (de) |
DE (1) | DE69429868T2 (de) |
DK (1) | DK0724600T3 (de) |
ES (1) | ES2173927T3 (de) |
FR (1) | FR2711371B1 (de) |
PT (1) | PT724600E (de) |
WO (1) | WO1995011260A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3626982B2 (ja) * | 1997-08-29 | 2005-03-09 | アークレイ株式会社 | タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット |
US6596705B1 (en) | 1998-02-09 | 2003-07-22 | The Regents Of The University Of California | Inhibition of L-selectin and P-selection mediated binding using heparin |
US6660482B1 (en) | 2000-02-28 | 2003-12-09 | Rhode Island Hospital | Inter-alpha-trypsin inhibitor as a marker for sepsis |
JP2004511492A (ja) * | 2000-10-13 | 2004-04-15 | オクタファルマ アクチェン ゲゼルシャフト | ビクニンを含む血漿画分、その調製方法、およびその使用 |
AU2003230985A1 (en) * | 2002-04-18 | 2003-11-03 | Stephen H. Embury | Method and composition for preventing pain in sickle cell patients |
EP1691820A4 (de) * | 2003-11-08 | 2010-03-03 | Prothera Biolog | Herstellung und zusammensetzung von inter-alpha-hemmer-proteinen aus menschlichem plasma für die therapeutische anwendung |
DK2291654T3 (en) | 2008-05-28 | 2018-06-14 | Prothera Biologics Inc | PREPARATION AND COMPOSITION OF BLOOD INTER-ALPHA INHIBITOR PROTEINS |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
AU2011280907B2 (en) * | 2010-07-23 | 2016-02-04 | Takeda Pharmaceutical Company Limited | Manufacture of inter -alpha - inhibitor proteins (IaIp) from plasma |
CA2885604A1 (en) | 2012-09-09 | 2014-03-13 | Prothera Biologics, Inc. | Treatment of ischemia using inter-alpha inhibitor proteins |
CN103880951B (zh) * | 2014-03-31 | 2016-03-30 | 南昌市万华生化制品有限公司 | 一种通过乌司他丁亲和层析介质制备纯品乌司他丁的方法 |
EP3362464B1 (de) * | 2015-10-15 | 2021-04-28 | Plasma Technologies LLC | Verfahren zur extraktion von proteinen aus blutplasma |
CN109776674B (zh) * | 2019-02-19 | 2020-01-17 | 广东天普生化医药股份有限公司 | 纯化的乌司他丁及其制备方法和含有该乌司他丁的药物组合物 |
CA3174478A1 (en) | 2020-03-05 | 2021-09-10 | DiaMedica USA Inc. | Ulinastatin polypeptides |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1434199A (fr) * | 1964-01-10 | 1966-04-08 | Behringwerke Ag | Procédé d'isolement d'inhibiteurs de la plasmine et de la trypsine à partir de liquides organiques d'origine humaine ou animale |
US4119774A (en) * | 1976-03-05 | 1978-10-10 | Ab Kabi | Heparin purification method |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
US4760130A (en) * | 1984-12-06 | 1988-07-26 | Synergen Biologicals, Inc. | Serine protease inhibitors and methods for isolation of same |
US4629567A (en) * | 1986-03-07 | 1986-12-16 | Smithkline-Rit | Alpha-1-antiprotease purification |
EP0317376B2 (de) * | 1987-10-23 | 1996-04-03 | Centre Regional De Transfusion Sanguine De Lille | Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat |
US5445958A (en) * | 1987-12-22 | 1995-08-29 | National Blood Authority | Process for purifying blood clotting factors |
-
1993
- 1993-10-18 FR FR9312346A patent/FR2711371B1/fr not_active Expired - Lifetime
-
1994
- 1994-10-17 ES ES94931070T patent/ES2173927T3/es not_active Expired - Lifetime
- 1994-10-17 EP EP94931070A patent/EP0724600B1/de not_active Expired - Lifetime
- 1994-10-17 WO PCT/FR1994/001197 patent/WO1995011260A1/fr active IP Right Grant
- 1994-10-17 JP JP51140495A patent/JP3650937B2/ja not_active Expired - Fee Related
- 1994-10-17 DE DE69429868T patent/DE69429868T2/de not_active Expired - Lifetime
- 1994-10-17 AT AT94931070T patent/ATE213252T1/de not_active IP Right Cessation
- 1994-10-17 DK DK94931070T patent/DK0724600T3/da active
- 1994-10-17 US US08/632,460 patent/US5777081A/en not_active Expired - Lifetime
- 1994-10-17 AU AU79962/94A patent/AU7996294A/en not_active Abandoned
- 1994-10-17 PT PT94931070T patent/PT724600E/pt unknown
- 1994-10-17 CA CA002174231A patent/CA2174231C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2174231C (fr) | 2004-06-01 |
FR2711371A1 (fr) | 1995-04-28 |
AU7996294A (en) | 1995-05-08 |
EP0724600A1 (de) | 1996-08-07 |
FR2711371B1 (fr) | 1995-12-29 |
EP0724600B1 (de) | 2002-02-13 |
WO1995011260A1 (fr) | 1995-04-27 |
ATE213252T1 (de) | 2002-02-15 |
US5777081A (en) | 1998-07-07 |
DE69429868T2 (de) | 2002-09-19 |
JP3650937B2 (ja) | 2005-05-25 |
ES2173927T3 (es) | 2002-11-01 |
PT724600E (pt) | 2002-07-31 |
JPH09503775A (ja) | 1997-04-15 |
CA2174231A1 (fr) | 1995-04-27 |
DK0724600T3 (da) | 2002-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE193020T1 (de) | Verfahren zur herstellung von immunoglobulin g konzentrat | |
DE69429868D1 (de) | Verfahren zur herstellung eines inter-alpha-trypsin inhibitor konzentrats mit therapeutischer anwendung und so erhaltenes konzentrat | |
ATE135908T1 (de) | Optisch reines r(-)albuterol zur behandlung von asthma | |
EP1839657A3 (de) | Verfahren zur Behandlung vaskulärer Kopfschmerzen | |
ZA966240B (en) | Methods for treatment of allergic asthma. | |
ES2114471A1 (es) | Nuevos compuestos de paroxetina y procedimiento para su preparacion. | |
DE59003771D1 (de) | Verfahren zur Herstellung von cyclischen Aminosäurederivaten sowie Zwischenprodukte. | |
DE69637593D1 (de) | Arteriovenöse und venöse transplantatbehandlungen: methoden und zusammensetzungen | |
NO951761L (no) | Stabilt preparat for behandling av blodkoagulasjonssykdommer | |
NO963785L (no) | Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser | |
ATE166230T1 (de) | Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock | |
ES2162929T3 (es) | Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario. | |
ATE307203T1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
DE69502675D1 (de) | Verfahren zur Herstellung von Bis(Aminomethyl)Cyclohexan | |
ATE131490T1 (de) | Verfahren zur herstellung von gereinigten albuminlösungen | |
AU4876196A (en) | A process for the preparation of factor ix from biological sources | |
ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
ATE152722T1 (de) | Verfahren zur herstellung von 9-(2-hydroxy)- ethoxy-guanin | |
ATE171620T1 (de) | Verwendung von verzweigtkettigen aminosäuren zur herstellung eines arzneimittels zur behandlung von tardiver dyskinesia | |
NO973366L (no) | Fremgangsmåte for behandling av multippel sklerose | |
ATE320263T1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
DE60034110D1 (de) | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien | |
DE69414586D1 (de) | Verfahren zur herstellung von indolizinderivaten | |
DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: L'ETABLISSEMENT FRANCAIS DU SANG, LA PLAINE SA, FR |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: CABINET HIRSCH & ASSOCIES, PARIS, FR |